Anesthetic Management of Pheochromocytoma and Paraganglioma

  • Ljuba Stojiljkovic
Part of the Contemporary Endocrinology book series (COE)


Pheochromocytoma and paraganglioma are rare endocrine tumors that pose significant challenge to anesthesiologists. Increased sympathetic activation during induction of anesthesia, tracheal intubation, and surgical incision, and surges of catecholamine release during manipulation of the tumor can precipitate severe hemodynamic instability. Intraoperative complications include malignant hypertension, arrhythmia, myocardial infarction, acute cardiac decompensation, pulmonary edema, and stroke. Careful preoperative preparation with α- and β-blockers and oral intravascular fluid expansion have been shown to decrease the incidence and severity of perioperative hemodynamic instability. Preoperative tests should include 24-h urine catecholamine levels and cardiac evaluation with an electrocardiogram and an echocardiogram. In addition to standard intraoperative monitors, all patients should have an arterial line placed prior to induction of anesthesia. Most patients receive general anesthesia for these surgeries. During the induction of anesthesia, a deep plain of anesthesia and paralysis should be achieved prior to tracheal intubation, to avoid excessive sympathetic stimulation. Potent arterial and venous vasodilators should be readily available to treat hypertensive crises during anesthesia. Arrhythmias should be treated promptly with β-blockers and antiarrhythmic agents. Vasopressors are usually needed to treat hypotension after tumor resection. All vasodilators and vasopressors should be infused via central venous access. Maintenance of general anesthesia is achieved with a volatile anesthetic, with the careful titration of narcotics. The goal of fluid management is to achieve euvolemia. Fluid management should be guided by dynamic parameters of fluid responsiveness. All patients should be recovered in an intensive care unit. Elderly patients are at higher risk for postoperative complications and prolonged hypotension after tumor resection. Care of pheochromocytoma in pregnancy requires a multidisciplinary approach with an endocrinologist, obstetrician, surgeon, and anesthesiologist to best prepare for the timing of surgical resection.


Choice of anesthesia Anesthetic monitoring Anesthetic agents Treatment of hemodynamic instability Hypertensive crisis Fluid management 


  1. 1.
    Ramakrishna H. Pheochromocytoma resection: current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015;31(3):317–23. PubMed PMID: 26330708. Pubmed Central PMCID: PMC4541176. Epub 2015/09/04. EngCrossRefGoogle Scholar
  2. 2.
    Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet (London, England). 2005;366(9486):665–75. PubMed PMID: 16112304. Epub 2005/08/23. engCrossRefGoogle Scholar
  3. 3.
    Fishbein L, Orlowski R, Cohen D. Pheochromocytoma/Paraganglioma: review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma. J Clin Hypertens (Greenwich). 2013;15(6):428–34. PubMed PMID: 23730992. Pubmed Central PMCID: PMC4581847. Epub 2013/06/05. engCrossRefGoogle Scholar
  4. 4.
    Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol. 2013;20(5):1444–50. PubMed PMID: 23512077. Pubmed Central PMCID: PMC4291281. Epub 2013/03/21. engCrossRefGoogle Scholar
  5. 5.
    Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia. 2005;60(5):439–44. PubMed PMID: 15819762. Epub 2005/04/12. engCrossRefGoogle Scholar
  6. 6.
    Apgar V, Papper EM. Pheochromocytoma. Anesthetic management during surgical treatment. AMA Arch Surg. 1951;62(5):634–48. PubMed PMID: 14818537. Epub 1951/05/01. engCrossRefGoogle Scholar
  7. 7.
    Kinney MA, Warner ME, van Heerden JA, Horlocker TT, Young WF Jr, Schroeder DR, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91(5):1118–23. PubMed PMID: 11049893. Epub 2000/10/26. engPubMedGoogle Scholar
  8. 8.
    Kramer CK, Leitao CB, Azevedo MJ, Canani LH, Maia AL, Czepielewski M, et al. Degree of catecholamine hypersecretion is the most important determinant of intra-operative hemodynamic outcomes in pheochromocytoma. J Endocrinol Investig. 2009;32(3):234–7. PubMed PMID: 19542740. Epub 2009/06/23. engCrossRefGoogle Scholar
  9. 9.
    Chang RY, Lang BH, Wong KP, Lo CY. High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma/paraganglioma removal. World J Surg. 2014;38(9):2317–23. PubMed PMID: 24782037. Epub 2014/05/02. engCrossRefGoogle Scholar
  10. 10.
    Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, et al. Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2016;159(3):763–70. PubMed PMID: 26477475. Epub 2015/10/20. engCrossRefGoogle Scholar
  11. 11.
    Phitayakorn R, McHenry CR. Perioperative considerations in patients with adrenal tumors. J Surg Oncol. 2012;106(5):604–10. PubMed PMID: 22513507. Epub 2012/04/20. EngCrossRefGoogle Scholar
  12. 12.
    Challis BG, Casey RT, Simpson HL, Gurnell M. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? Clin Endocrinol. 2017;86(2):163–7. PubMed PMID: 27696513. Epub 2016/10/25. engCrossRefGoogle Scholar
  13. 13.
    Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156(6):1410–7. discussion7-8. PubMed PMID: 25456922. Epub 2014/12/03. engCrossRefGoogle Scholar
  14. 14.
    Wachtel H, Kennedy EH, Zaheer S, Bartlett EK, Fishbein L, Roses RE, et al. Preoperative Metyrosine improves cardiovascular outcomes for patients undergoing surgery for Pheochromocytoma and Paraganglioma. Ann Surg Oncol. 2015;22(Suppl 3):S646–54. PubMed PMID: 26374407. Epub 2015/09/17. engCrossRefGoogle Scholar
  15. 15.
    Roizen A. Prospective randomized trial of four anesthetic techniques for resection of pheochromocytoma. Anesthesiology. 1982;57: A43.CrossRefGoogle Scholar
  16. 16.
    Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Task Force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology. 2017 PubMed PMID: 28045707. Epub 2017/01/04. eng.Google Scholar
  17. 17.
    STANDARDS FOR BASIC ANESTHETIC MONITORING [Web Document]. American Society of Anesthesiologists; 2015 [updated October 28, 2015; cited 2017 2/6/2017].
  18. 18.
    Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database Syst Rev, 2013; July 03 (7):Cd004087. PubMed PMID: 23824697. Epub 2013/07/05. engGoogle Scholar
  19. 19.
    Usubiaga JE, Wikinski JA, Usubiaga LE. Use of lidocaine and procaine in patients with pheochromocytoma. Anesth Analg. 1969;48(3):443–53. PubMed PMID: 5815109. Epub 1969/05/01. engCrossRefGoogle Scholar
  20. 20.
    Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992;76(5):725–33. PubMed PMID: 1575340. Epub 1992/05/01. engCrossRefGoogle Scholar
  21. 21.
    Stoner TR Jr, Urbach KF. Cardiac arrhythmias associated with succinylcholine in a patient with pheochromocytoma. Anesthesiology. 1968;29(6):1228–9. PubMed PMID: 5726757. Epub 1968/11/01. engCrossRefGoogle Scholar
  22. 22.
    Joffe D, Robbins R, Benjamin A. Caesarean section and phaeochromocytoma resection in a patient with von Hippel Lindau disease. Can J Anaesth J Can d'anesthesie. 1993;40(9):870–4. PubMed PMID: 8403182. Epub 1993/09/01. engCrossRefGoogle Scholar
  23. 23.
    Tomulic K, Saric JP, Kocman B, Skrtic A, Filipcic NV, Acan I. Successful management of unsuspected retroperitoneal paraganglioma via the use of combined epidural and general anesthesia: a case report. J Med Case Rep. 2013;7:58. PubMed PMID: 23448279. Pubmed Central PMCID: PMC3599738. Epub 2013/03/02. engCrossRefGoogle Scholar
  24. 24.
    Nizamoglu A, Salihoglu Z, Bolayrl M. Effects of epidural-and-general anesthesia combined versus general anesthesia during laparoscopic adrenalectomy. Surg Laparosc Endosc Percutan Tech. 2011;21(5):372–9. PubMed PMID: 22002277. Epub 2011/10/18. engCrossRefGoogle Scholar
  25. 25.
    Luo A, Guo X, Yi J, Ren H, Huang Y, Ye T. Clinical features of pheochromocytoma and perioperative anesthetic management. Chin Med J. 2003;116(10):1527–31. PubMed PMID: 14570616. Epub 2003/10/23. engPubMedGoogle Scholar
  26. 26.
    O’Riordan JA. Pheochromocytomas and anesthesia. Int Anesthesiol Clin. 1997;35(4):99–127. PubMed PMID: 9444533. Epub 1998/01/28. engGoogle Scholar
  27. 27.
    Ebert TJ, Muzi M. Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology. 1993;79(3):444–53. PubMed PMID: 8363068. Epub 1993/09/01. engCrossRefGoogle Scholar
  28. 28.
    El-Galley R, Hammontree L, Urban D, Pierce A, Sakawi Y. Anesthesia for laparoscopic donor nephrectomy: is nitrous oxide contraindicated? J Urol. 2007;178(1):225–7. discussion 7. PubMed PMID: 17512015. Epub 2007/05/22. engCrossRefGoogle Scholar
  29. 29.
    Sun R, Jia WQ, Zhang P, Yang K, Tian JH, Ma B, et al. Nitrous oxide-based techniques versus nitrous oxide-free techniques for general anaesthesia. Cochrane Database Syst Rev. 2015; Nov 6 (11):Cd008984. PubMed PMID: 26545294. Epub 2015/11/07. engGoogle Scholar
  30. 30.
    Breslin DS, Farling PA, Mirakhur RK. The use of remifentanil in the anaesthetic management of patients undergoing adrenalectomy: a report of three cases. Anaesthesia. 2003;58(4):358–62. PubMed PMID: 12648118. Epub 2003/03/22. EngCrossRefGoogle Scholar
  31. 31.
    Ali Erdogan M, Selim Ozkan A, Ozgul U, Colak Y, Ucar M. Dexmedetomidine, Remifentanil, and Sevoflurane in the perioperative Management of a Patient during a laparoscopic Pheochromocytoma resection. J Cardiothorac Vasc Anesth. 2015;29(6):e79–80. PubMed PMID: 26411814. Epub 2015/09/29. EngCrossRefGoogle Scholar
  32. 32.
    Hughes RE, Magovern GJ. The relationship between right atrial pressure and blood volume. AMA Arch Surg. 1959;79(2):238–43. PubMed PMID: 13669851. Epub 1959/08/01. engCrossRefGoogle Scholar
  33. 33.
    Wilson JN, Grow JB, Demong CV, Prevedel AE, Owens JC. Central venous pressure in optimal blood volume maintenance. Arch Surg (Chicago, Ill: 1960). 1962;85:563–78. PubMed PMID: 14001047. Epub 1962/10/01. engCrossRefGoogle Scholar
  34. 34.
    Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172–8. PubMed PMID: 18628220. Epub 2008/07/17. engCrossRefGoogle Scholar
  35. 35.
    Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774–81. PubMed PMID: 23774337. Epub 2013/06/19. engCrossRefGoogle Scholar
  36. 36.
    Legrand G, Ruscio L, Benhamou D, Pelletier-Fleury N. Goal-directed fluid therapy guided by cardiac monitoring during high-risk abdominal surgery in adult patients: cost-effectiveness analysis of esophageal Doppler and arterial pulse pressure waveform analysis. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2015;18(5):605–13. PubMed PMID: 26297088. Epub 2015/08/25. engCrossRefGoogle Scholar
  37. 37.
    Hack H. Use of the esophageal Doppler machine to help guide the intraoperative management of two children with pheochromocytoma. Paediatr Anaesth. 2006;16(8):867–76. PubMed PMID: 16884470. Epub 2006/08/04. engPubMedGoogle Scholar
  38. 38.
    Kinney MA, Narr BJ, Warner MA. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2002;16(3):359–69. PubMed PMID: 12073213. Epub 2002/06/20. engCrossRefGoogle Scholar
  39. 39.
    Subramaniam R. Pheochromocytoma – current concepts in diagnosis and management. Trends Anaesth Crit Care. 2011;1(2):104–10.CrossRefGoogle Scholar
  40. 40.
    Friederich JA, Butterworth JF. Sodium nitroprusside: twenty years and counting. Anesth Analg. 1995;81(1):152–62. PubMed PMID: 7598246. Epub 1995/07/01. engPubMedGoogle Scholar
  41. 41.
    Boden WE, Padala SK, Cabral KP, Buschmann IR, Sidhu MS. Role of short-acting nitroglycerin in the management of ischemic heart disease. Drug Des Devel Ther. 2015;9:4793–805. PubMed PMID: 26316714. Pubmed Central PMCID: PMC4548722. Epub 2015/09/01. engPubMedPubMedCentralGoogle Scholar
  42. 42.
    Lord MS, Augoustides JG. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth. 2012;26(3):526–31. PubMed PMID: 22361482. Epub 2012/03/01. EngCrossRefGoogle Scholar
  43. 43.
    Kwon SY, Lee KS, Lee JN, Ha YS, Choi SH, Kim HT, et al. Risk factors for hypertensive attack during pheochromocytoma resection. Investig Clin Urol. 2016;57(3):184–90. PubMed PMID: 27194549. Pubmed Central PMCID: PMC4869566. Epub 2016/05/20. EngCrossRefGoogle Scholar
  44. 44.
    Kiernan CM, Du L, Chen X, Broome JT, Shi C, Peters MF, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21(12):3865–71. PubMed PMID: 24939623. Pubmed Central PMCID: PMC4192065. Epub 2014/06/19. EngCrossRefGoogle Scholar
  45. 45.
    Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105(3):599–612. quiz 39-40. PubMed PMID: 16931995. Epub 2006/08/26. engCrossRefGoogle Scholar
  46. 46.
    Roth JV. Use of vasopressin bolus and infusion to treat catecholamine-resistant hypotension during pheochromocytoma resection. Anesthesiology. 2007;106(4):883–4. PubMed PMID: 17413940. Epub 2007/04/07. engCrossRefGoogle Scholar
  47. 47.
    Tan SG, Koay CK, Chan ST. The use of vasopressin to treat catecholamine-resistant hypotension after phaeochromocytoma removal. Anaesth Intensive Care. 2002;30(4):477–80. PubMed PMID: 12180588. Epub 2002/08/16. engPubMedGoogle Scholar
  48. 48.
    Brunaud L, Nguyen-Thi PL, Mirallie E, Raffaelli M, Vriens M, Theveniaud PE, et al. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc. 2016;30(3):1051–9. PubMed PMID: 26092019. Epub 2015/06/21. EngCrossRefGoogle Scholar
  49. 49.
    Srougi V, Chambo JL, Tanno FY, Soares IS, Almeida MQ, Pereira MA, et al. Presentation and surgery outcomes in elderly with pheocromocytoma: a comparative analysis with young patients. Int Braz J Urol Off J Braz Soc Urol. 2016;42(4):671–7. PubMed PMID: 27564276. Pubmed Central PMCID: PMC5006761. Epub 2016/08/27. engCrossRefGoogle Scholar
  50. 50.
    Dugas G, Fuller J, Singh S, Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can J Anaesth J Can d'anesthesie. 2004;51(2):134–8. PubMed PMID: 14766689. Epub 2004/02/10. EngCrossRefGoogle Scholar
  51. 51.
    Jayatilaka G, Abayadeera A, Wijayaratna C, Senanayake H, Wijayaratna M. Phaeochromocytoma during pregnancy: anaesthetic management for a caesarean section combined with bilateral adrenalectomy. Ceylon Med J. 2013;58(4):173–4. PubMed PMID: 24385061. Epub 2014/01/05. EngCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyNorthwestern University, Feinberg School of Medicine, Northwestern Medical GroupChicagoUSA

Personalised recommendations